Dr. Pollack's research centers on translational genomics, with a focus on human cancer. An original pioneer of array-based comparative genomic hybridization, his lab now uses next-generation sequencing, single-cell genomics, genome editing, and human cell/tissue-based modeling to uncover diseases mechanisms, biomarkers and therapeutic targets. Current areas of emphasis include diseases of the prostate (prostate cancer and benign prostatic hyperplasia), as well as odontogenic neoplasms.
Dr. Pollack was the 2006 recipient of the American Society of Investigative Pathology Amgen Outstanding Investigator Award, a national recognition awarded for research excellence in experimental pathology to an investigator under the age of 45. He is also an Elected Member of the American Society for Clinical Investigation, and has authored over 115 research publications.
Dr. Pollack completed his undergraduate degree at Harvard College, then his MD, PhD (Biochemistry), and clinical pathology residency training at the University of California, San Francisco. Following research fellowship training in genomics at Stanford University, he joined the faculty in 2001. In addition to his research, he has served as founding Director of the Stanford Tissue Bank.